|
HS Code |
668664 |
| Generic Name | Eflornithine Hydrochloride |
| Brand Names | Vaniqa, Ornidyl |
| Chemical Formula | C6H12F2N2O2 · HCl |
| Drug Class | Ornithine decarboxylase inhibitor |
| Primary Use | Treatment of facial hirsutism in women |
| Route Of Administration | Topical, Intravenous |
| Molecular Weight | 222.17 g/mol (base compound) |
| Mechanism Of Action | Inhibits ornithine decarboxylase enzyme |
| Appearance | White to off-white crystalline powder |
| Cas Number | 700-81-8 |
| Storage Conditions | Store below 25°C, protect from light and moisture |
| Dosage Form | Cream, Injectable solution |
| Prescription Status | Prescription only |
| Side Effects | Irritation, erythema, rash |
As an accredited Eflornithine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic container with a secure screw cap, labeled "Eflornithine Hydrochloride 100g," featuring hazard symbols and storage instructions. |
| Shipping | Eflornithine Hydrochloride is shipped in tightly sealed, moisture-resistant containers, protected from light and stored at controlled room temperature. It is classified for safe transport, typically labeled as a non-hazardous pharmaceutical, and accompanied by material safety data sheets. Handle with care to avoid contamination or degradation during transit. |
| Storage | Eflornithine hydrochloride should be stored in a tightly closed container at a controlled room temperature, typically between 15°C and 30°C (59°F to 86°F). It should be kept away from moisture, light, and incompatible substances. Proper labeling and secure storage are recommended to prevent unauthorized access and to maintain chemical stability and potency. |
Applications of Eflornithine Hydrochloride in Industrial ManufacturingEflornithine Hydrochloride serves critical roles as an active pharmaceutical ingredient and topical agent across multiple regulated manufacturing sectors. As a direct manufacturer, we collaborate with global industry partners to integrate this raw material into high-value downstream products, ensuring adherence to international safety and quality protocols across each application environment. 1. Prescription Hirsutism Cream ManufacturingMajor pharmaceutical manufacturers incorporate Eflornithine Hydrochloride in the production of topical creams formulated for the treatment of facial hirsutism, especially for women affected by unwanted facial hair due to hormone imbalance or genetic predisposition. Downstream producers conduct formulation adjustments based on clinical efficacy and patient tolerance data, while optimizing stability during both bulk manufacture and commercial packaging. Quality control laboratories routinely validate content uniformity, in accordance with regulatory filings, to guarantee dosage reliability across batches. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Parenteral Trypanosomiasis Drug ProductionInjectable formulations designed to treat African trypanosomiasis (sleeping sickness) rely on pharmaceutical-grade Eflornithine Hydrochloride. Manufacturing partners produce sterile, pyrogen-free lyophilized powders or solution-for-injection presentations intended for tropical disease programs and hospital-based therapies under stringent aseptic controls. Raw material quality directly influences final dosage purity and reconstitution stability, with close documentation of chain-of-custody throughout batch manufacture and regulatory lot release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. API Bulk Synthesis for Contract Manufacturing Organizations (CMOs)Bulk supply of Eflornithine Hydrochloride supports CMOs producing customized APIs for life sciences partners engaged in extended supply chains or niche therapeutic programs. These facilities follow rigorous batch documentation, stability testing, and retesting protocols to ensure compliant API delivery. The material’s purity profile, validated during our own in-process analytical testing, underpins both small- and large-volume downstream synthesis within multi-use pharmaceutical reactors, supporting both originator and generic drug pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research-Grade Reference Material ProductionResearchers and clinical trial support labs source Eflornithine Hydrochloride as analytical reference material for development and validation of HPLC, GC-MS, and bioanalytical assays in support of drug discovery and pharmacokinetic studies. Accurate lot-to-lot consistency is pivotal, enabling robust method validation across regulatory filings and batch-release testing of clinical trial samples in regulated laboratory environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Eflornithine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working on the synthesis and scale-up of Eflornithine Hydrochloride each day underscores its place in specialized pharmaceuticals. Our production crews see every batch from raw amino acid feedstock through reaction, purification, and drying. We have spent years improving the crystallization and salt formation steps, and our approach ensures the hydrochloride salt emerges reliably batch after batch. Each lot brings its own challenges, from purity demands to precise moisture content. No one here confuses bulk manufacturing with secondary repackaging — real quality measures live in the details of bulk crystallization, not just the paperwork.
We supply Eflornithine Hydrochloride in both technical and pharmaceutical grades, and offer both bulk powder and finished ingredient formats. Typical particle sizes land in the manageable range for both compounding pharmacies and formulation lines — not too powdery, not too coarse. Purity levels achieved during synthesis run upward of 99%, but real value shows in keeping heavy metal content below strictly enforced thresholds. For moisture levels we target 0.5%-1.5%, so material neither cakes nor invites hydrolysis in long-term storage. End users in pharmaceutical manufacturing look for this version because it sits comfortably within compendial needs, and our quality team monitors each production day with in-process analytics and batchwise certified testing.
Real experience with this compound differs greatly from textbook summaries. Most of our output finds a home as an active pharmaceutical ingredient for topical preparations. Its unique enzyme-blocking action turns it into a frontline defense against unwanted facial hair growth in sensitive individuals. Other uses appear in research labs that pursue protozoan and trypanosome biology: Eflornithine Hydrochloride remains a rare compound that interrupts parasite metabolism without causing systemic toxicity typical of earlier generations of drugs. For our part as a manufacturer, batch consistency means clinical trial teams and generic pharmaceutical makers can maintain steady product development timelines.
Many of our customers tried third-party traders before reaching back to the actual manufacturing source. One difference arises immediately in the lot-to-lot variation — traders often ship a brokered inventory of unknown storage history, and the resulting product may fail to meet the same organoleptic or lab standards as freshly synthesized Eflornithine Hydrochloride. We commit to direct manufacturing and offer batch traceability from raw material intake onward. Most tests for d-alpha isomeric impurities, chloride ion content, and residual solvent levels can only be traced by manufacturers with in-house QC. If a pharma buyer requests documentation, our team can provide the full analytical path, because the sample never left our direct chain of custody. Not every powder is the same, and only direct manufacturing knows the root cause of an outlier in color, solubility, or reactivity.
In our experience, many overlook what sets Eflornithine Hydrochloride apart from other amino acid derivatives. Unlike cyclohexylamine-based enzyme inhibitors, this molecule works via ornithine decarboxylase inhibition, delivering a highly targeted mode of action. Other compounds in dermatology either suppress follicles non-specifically (leading to excessive irritation), or rely on older hormonal effects that invite systemic side effects. By contrast, topical Eflornithine Hydrochloride has shown reliable safety in multicenter studies, which explains why demand holds steady in regulated markets. Unlike alternative actives shipped as esters or oily suspensions, this hydrochloride salt remains water soluble at room temperature — easily incorporated into both creams and gels without risk of precipitation during shelf life.
In a large batch production setting, the importance of batch-to-batch uniformity cannot be overstated. Eflornithine Hydrochloride’s fine-particle forms must blend easily with excipients, so we keep polymorph control and particle size distribution under tight check. Frequent investments go into robust process controls: fixed-bed reactor parameters, moisture control in finishing, rapid drying systems, and strict packing lines. Process-induced impurities (such as those derived from incomplete neutralization or oxidized side products) get swept up during our multi-stage purification, which cannot be replicated by simple remilling or repackaging further down the supply chain.
Our in-house laboratories perform a suite of characterization steps on every product lot. High-performance liquid chromatography quantifies major and trace impurities, while gas chromatography ensures no detectable residual solvent remains post-drying. Spectroscopic identification confirms identity and salt form, flagging any deviations early in production. Every time an outside inspection or customer audit arrives, we open up our facilities to show documented evidence, not just certificates. Buyers approaching us with specific questions on raw material origins, roast histories of amino acid feedstocks, or validation protocols receive detailed records tracing product lineage beyond superficial documentation.
Eflornithine Hydrochloride users in regulated markets need clear confirmation that their starting material will match specifications from one purchase to the next. Our process development groups consult directly with regulatory compliance officers to make sure production steps match the latest requirements from US, EU, and other leading agencies. Environmental and safety requirements add further scrutiny: waste streams, operator training, and documentation all come under review as part of our daily operation. Our familiarity with pharmacopoeial standards — including both USP and EP monograph targets — keeps us ahead of ad hoc changes or surprise notices from regulatory agencies.
Experience has shown that Eflornithine Hydrochloride responds differently to various cream and gel bases. Its water solubility gives it compatibility with a broad suite of excipients, yet formulating teams prefer our bulk powder grade because of its stability profile. Those who have tried more basic derivatives (like freebase Eflornithine or alternate salt forms) run into issues during formulation: precipitation, phase separation, or compromised shelf life. Our manufacturing line focuses on control of residual acidity and ion balance, so formulators can skip lengthy pre-testing and jump straight to in-house development.
We often hear from procurement teams frustrated with long lead times or inconsistent product from secondary suppliers. Chemical markets have grown crowded with intermediaries who offer what appears to be the same material but deliver variable performance. Actual manufacturers, by contrast, hold clear records for every step: starting material test reports, environmental monitoring logs, photographic shipment records, temperature control during warehousing, and secured bulk shipment. This level of documentation keeps downstream users out of trouble during regulatory audits and reassures end-customers that finished products truly meet label claims.
Actual production experience with Eflornithine Hydrochloride gives unique insight into how the compound should be handled and stored for long-term stability. Finished bulk batches require moisture-tight packaging and, where humid climates prevail, a secondary desiccant layer. Standard temperature storage between 15 and 25°C preserves the active site of the compound. Even during temporary warehousing, shipment temperature logs must be monitored. Facilities that have grown accustomed to commodity-chemical management must reconsider risk of hydrolysis and degradation specific to this pharmaceutical molecule. Investing in tight-seal containers and controlled storage pays off with real retention in shelf-life and patient reliability.
Within our plant, we maintain a closed system for liquid and solid waste streams, strictly treating byproducts before responsible disposal. Operators wear personal protective gear, and air handling systems filter dust and minimize exposure. Rooted in years of manufacturing discipline, our protocols leave nothing to chance. We do not simply meet minimum requirements set by local environmental regulators — we implement proactive audits and update documentation frequently. Waste from Eflornithine Hydrochloride production sees dedicated handling, never mixing with unrelated stream or solvent residue.
Direct communication with our technical teams leads to smarter, smoother production outcomes for our customers. Whether resolving issues related to unexpected color shifts, solubility challenges, or compatibility with new excipients, having access to the original production chemists speeds up problem solving. Traders and third-party resellers can forward messages, but rarely provide experiential advice for in-process troubleshooting. Our teams understand which process adjustments (particle size, ionic strength, drying cycle) will make a difference in finished batch quality.
Bulk logistics form an overlooked but essential segment of our business. From specialized liners and drum materials to temperature-resistant shipping units, every variable affects product safety. Bulk shipping documents confirm uninterrupted custody, and electronic systems monitor location and environmental conditions throughout transport. Unlike non-specialist shippers, we anticipate port delays and customs hurdles, building lead time buffers to shield clients from last-minute disruptions. Our experience as heavy industrial manufacturers goes deeper than loading trucks — it informs our entire planning, from lot release scheduling to regional supply chain forecasts.
Feedback from end users often sparks new development cycles on our line. If a major pharmaceutical company reports stronger results with a tighter particle size range or requests lower heavy metal content, we carry lessons forward into future production. Our process engineers adjust reactors, fine-tune filter beds, and implement automation upgrades as direct responses to market evolution. This manufacturer-driven continuous improvement keeps us responsive and adaptable, especially across evolving global quality regimes and supply chain shifts.
Genuine quality assurance happens on the warehouse floor and during in-process checks, not only in final documentation. Our staff understand the entire journey of the compound, from reactor to drum. Quality managers catch anomalies during manufacturing, not at the far end of the logistics train. Finished product in our plant warehouse has completed rigorous stability studies, so customers can rely on both established shelf lives and accelerated aging data.
We notice tangible trends in the end markets for Eflornithine Hydrochloride. As awareness of dermatological therapies expands, demand rises for raw materials that meet renewed consumer safety expectations. Users report greater confidence working directly with ingredient manufacturers who offer both consistent supply and transparent documentation. Development programs for new topical products intensify every year, and pharmaceutical companies prefer predictable input material when launching regulated health products. Every kilogram we ship out represents months of refinement at the bench and steady execution in scaled reaction vessels. When users encounter a challenge, our internal teams can often trace the path from reactor kinetics to powder shipment.
Our operations team brings together synthetic chemistry and applied pharmaceutical science. Every change to the process — purification time, solvent grade, agitation speed, filtration pressure — receives a documented trial and impact assessment. We test assumptions in the lab before implementation at the production scale. This foundation separates the regulated manufacturing world from shortcuts found in unregulated supply chains.
Price volatility and raw material disruption challenge every specialty chemical operation. We track reliable sources for feedstock so unforeseen shortages create minimal impact. Transparent sourcing and documented agreements insulate our supply partners from unexpected price swings. Our direct relationship with buyers outlasts market cycles. By keeping transparent dialogue open, we anticipate needs and allocate new capacity to customers with evolving demand, even amid external instability.
We see customer relationships as long-term partnerships rooted in technical transparency. As formulation trends change, and as regulatory agencies revise standards, our process teams update both product and supporting documentation in tandem. We work side-by-side with pharmaceutical companies engaged in new research, offering material samples for preclinical and pilot-scale testing. Not every manufacturing plant exposes its process innovation cycle so openly — but for us, these conversations build trust, helping customers optimize their finished doses and gain speed to market.
Each lot of Eflornithine Hydrochloride produced by our teams receives a full chain-of-custody log: from the starting batch of raw amino acid through chemical synthesis, isolation, drying, and finished packing. Analytical records support every stage, and auditors have access to both paper and digital files. This closed-loop approach removes uncertainty in tracing any detected issue, enabling both preemptive solutions at the root and faster recovery in the rare event of a manufacturing concern. Customers can request supporting data packages that cover not just finished lot release, but also process environment and operator training logs.
Year after year, development pipelines in both generic and branded pharmaceuticals require ingredients that perform reliably through scale-up, stability testing, and regulatory submission. That journey depends on consistent ingredient identity and traceable production — not just purity on a piece of paper. Our long history in Eflornithine Hydrochloride manufacturing stems from disciplined investment in both process infrastructure and production science. This stewardship lets us support clinical trials and commercial production in a way that piecemeal or brokered sources cannot.
For those in pharmaceutical manufacturing, Eflornithine Hydrochloride stands as a precisely controlled, technically challenging ingredient where consistency and quality steer the entire downstream process. Our know-how derives from real-world practice, day in and day out, delivering both reliability and peace of mind. Open dialogue, traceable production, and a willingness to adapt drive our commitment to supporting every partner who builds new therapies or improves existing pathways for patient care.